Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Tamara Intermesoli"'
Autor:
Giuliana Rizzuto, Federico Mazzon, Chiara Pavoni, Anna Maria Barbui, Silvia Ferrari, Giuseppe Gritti, Anna Grassi, Federico Lussana, Tamara Intermesoli, Alessandro Rambaldi
Publikováno v:
HemaSphere, Vol 7, p e39998b5 (2023)
Externí odkaz:
https://doaj.org/article/6b602d51fc014f6cb0a35fe59ab64483
Autor:
Gabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, Luciano Levato, Tamara Intermesoli, Mariella D'Adda, Marzia Salvucci, Fabio Stagno, Giovanna Rege-Cambrin, Mario Tiribelli, Bruno Martino, Monica Bocchia, Michele Cedrone, Elena Trabacchi, Francesco Cavazzini, Ferdinando Porretto, Federica Sorà, Maria Pina Simula, Francesco Albano, Simona Soverini, Robin Foà, Fabrizio Pane, Michele Cavo, Giuseppe Saglio, Michele Baccarani, Gianantonio Rosti
Publikováno v:
Haematologica, Vol 107, Iss 10 (2022)
We report the final analysis, with a 10-year follow-up, of the phase II study GIMEMA CML 0307 (NCT 00481052), which enrolled 73 adult patients (median age 51 years; range, 18-83) with newly diagnosed chronic-phase chronic myeloid leukemia to investig
Externí odkaz:
https://doaj.org/article/a405282ce52c4b72b65440d9cc8fad84
Autor:
Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, Roberta Cavagna, Ksenija Buklijas, Lara Elidi, Pamela Zanghi', Anna Michelato, Federica Delaini, Elena Oldani, Tamara Intermesoli, Anna Grassi, Giacomo Gianfaldoni, Francesco Mannelli, Dario Ferrero, Ernesta Audisio, Elisabetta Terruzzi, Lorella De Paoli, Chiara Cattaneo, Erika Borlenghi, Irene Cavattoni, Monica Tajana, Anna Maria Scattolin, Daniele Mattei, Paolo Corradini, Leonardo Campiotti, Fabio Ciceri, Massimo Bernardi, Elisabetta Todisco, Agostino Cortelezzi, Brunangelo Falini, Chiara Pavoni, Renato Bassan, Orietta Spinelli, Alessandro Rambaldi
Publikováno v:
Haematologica, Vol 106, Iss 10 (2020)
Secondary acute myeloid leukemia (sAML) after myelodysplastic or myeloproliferative disorders is a high-risk category currently identified by clinical history or specific morphological and cytogenetic abnormalities. However, in the absence of these f
Externí odkaz:
https://doaj.org/article/86512554f32e4819856fc359461fbc77
Autor:
Gabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, Francesco Albano, Alessandra Iurlo, Tamara Intermesoli, Elisabetta Abruzzese, Luciano Levato, Mariella D’Adda, Patrizia Pregno, Francesco Cavazzini, Fabio Stagno, Bruno Martino, Gaetano La Barba, Federica Sorà, Mario Tiribelli, Catia Bigazzi, Gianni Binotto, Massimiliano Bonifacio, Clementina Caracciolo, Simona Soverini, Robin Foà, Michele Cavo, Giovanni Martinelli, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani, Gianantonio Rosti
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
The majority of patients with chronic myeloid leukemia are successfully managed with life-long treatment with tyrosine kinase inhibitors. In patients in chronic phase, other malignancies are among the most common causes of death, raising concerns on
Externí odkaz:
https://doaj.org/article/3bac5e13883447c2b932ce41dbaaadcb
Autor:
Silvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta, Pamela Zanghi, Elena Oldani, Cristina Boschini, Alexander Kohlmann, Silvia Bungaro, Tamara Intermesoli, Elisabetta Terruzzi, Emanuele Angelucci, Irene Cavattoni, Fabio Ciceri, Renato Bassan, Alessandro Rambaldi, Orietta Spinelli
Publikováno v:
Haematologica, Vol 101, Iss 6 (2016)
Externí odkaz:
https://doaj.org/article/4a2229056a3646a8b400c57bafdd4f51
Autor:
Renato Bassan, Arianna Masciulli, Tamara Intermesoli, Ernesta Audisio, Giuseppe Rossi, Enrico Maria Pogliani, Vincenzo Cassibba, Daniele Mattei, Claudio Romani, Agostino Cortelezzi, Consuelo Corti, Anna Maria Scattolin, Orietta Spinelli, Manuela Tosi, Margherita Parolini, Filippo Marmont, Erika Borlenghi, Monica Fumagalli, Sergio Cortelazzo, Andrea Gallamini, Rosa Maria Marfisi, Elena Oldani, Alessandro Rambaldi
Publikováno v:
Haematologica, Vol 100, Iss 6 (2015)
Developing optimal radiation-free central nervous system prophylaxis is a desirable goal in acute lymphoblastic leukemia, to avoid the long-term toxicity associated with cranial irradiation. In a randomized, phase II trial enrolling 145 adult patient
Externí odkaz:
https://doaj.org/article/5cc9ce3243834d5d8ea2c0feb55dd0c8
Autor:
Tamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, Federica Delaini, Claudio Romani, Enrico Maria Pogliani, Chiara Pagani, Emanuele Angelucci, Elisabetta Terruzzi, Alessandro Levis, Vincenzo Cassibba, Daniele Mattei, Giacomo Gianfaldoni, Anna Maria Scattolin, Eros Di Bona, Elena Oldani, Margherita Parolini, Nicola Gökbuget, Renato Bassan
Publikováno v:
Haematologica, Vol 98, Iss 11 (2013)
We evaluate the long-term results of a prospective clinical study enrolling more than 100 adult patients with Burkitt lymphoma/leukemia. Depending on extent of disease, treatment consisted of six to eight rituximab infusions and four to six courses o
Externí odkaz:
https://doaj.org/article/bf3bfa18f9264bb7b13fe32de4aaa3d1
Autor:
Francesco Mannelli, Giacomo Gianfaldoni, Tamara Intermesoli, Chiara Cattaneo, Erika Borlenghi, Sergio Cortelazzo, Irene Cavattoni, Enrico Maria Pogliani, Monica Fumagalli, Emanuele Angelucci, Claudio Romani, Fabio Ciceri, Consuelo Corti, Anna Scattolin, Agostino Cortelezzi, Daniele Mattei, Ernesta Audisio, Orietta Spinelli, Elena Oldani, Alberto Bosi, Alessandro Rambaldi, Renato Bassan
Publikováno v:
Haematologica, Vol 97, Iss 4 (2012)
The prognostic significance of CD20 expression in acute lymphoblastic leukemia has been investigated in children and adults but is still a subject of debate. The aim of our study was to correlate CD20 expression with clinical-biological characteristi
Externí odkaz:
https://doaj.org/article/4ad4800044f441ec9ab4494e46d6c3e8
Autor:
Nicola Gökbuget, Christina-Maria Hartog, Renato Bassan, Heinz-Gerd Derigs, Herve Dombret, Richard Greil, Jesus-Maria Hernández-Rivas, Francoise Huguet, Tamara Intermesoli, Eric Jourdan, Christian Junghanss, Lothar Leimer, Maria-Jose Moreno, Albrecht Reichle, Josep Ribera, Matthias Schmid, Hubert Serve, Matthias Stelljes, Reingard Stuhlmann, Dieter Hoelzer
Publikováno v:
Haematologica, Vol 96, Iss 2 (2011)
Background Treatment of central nervous system relapse in adult acute lymphoblastic leukemia is a challenge and outcome is poor. Liposomal cytarabine has a prolonged half-life and, given intrathecally, has produced high response rates in patients wit
Externí odkaz:
https://doaj.org/article/c06780166d684e64a9f8dc634b313cbc
Autor:
Francesca Palandri, Ilaria Iacobucci, Fausto Castagnetti, Nicoletta Testoni, Angela Poerio, Marilina Amabile, Massimo Breccia, Tamara Intermesoli, Francesco Iuliano, Giovanna Rege-Cambrin, Mario Tiribelli, Maurizio Miglino, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli, Gianantonio Rosti, Michele Baccarani, on behalf of the GIMEMA Working Party on CML
Publikováno v:
Haematologica, Vol 93, Iss 5 (2008)
In 2004, we reported the short-term results of a multicentric, phase 2 study of imatinib 400 mg daily and pegylated interferon-α in the treatment of 76 early chronic phase Philadelphia-positive chronic myeloid leukemia patients. In this report, we u
Externí odkaz:
https://doaj.org/article/e5afe5a76abf48f0ba310e69e2960d53